Professional Documents
Culture Documents
Vision: Making effective communication, a human right, accessible and achievable for all.
Support Restoring Funding for the Individuals with Disabilities Education Act (IDEA)
Support Preserving Medicaid Coverage for Audiology and Speech-Language Pathology Services
Support Medicare Telehealth Coverage for Audiology and Speech-Language Pathology Services
Support Reauthorization of the Early Hearing Detection and Intervention (EHDI) Program
EDUCATION ISSUES
Support Alternatives to Applied
Behavior Analysis (ABA) Therapy
All appropriate therapies should be provided to
children with autism spectrum disorder (ASD). There
is a growing trend in both education and health care
to solely utilize applied behavioral analysis (ABA)
specialists to provide services to children identified
with autism spectrum disorder. Although ABA may
be an effective therapy, so are others, such as
speech-language pathology. In many cases,
insurance companies are denying speech-language
pathology claims where children are receiving ABA
services. ASHA does not oppose the use of ABA
services; however, singling it out in legislation as the
only treatment for behavioral health issues for
individuals with developmental disabilities, including
those with ASD, limits consumer choice.
Congress should not pass health care or education
legislation that could have the unintended
consequence of designating applied behavioral
analysis (ABA) therapy as the sole means by which
to treat ASD.
HEALTH ISSUES
Repeal the Medicare Outpatient Therapy Cap
Support the Medicare Access to Rehabilitation Services Act of 2015 (H.R.
775/S. 539), legislation that would repeal the Medicare outpatient therapy
cap and ensure Medicare patients continue to have access to medically
necessary speech-language pathology, occupational therapy, and physical
therapy services. A repeal of the Medicare therapy cap should also be
included in any Sustainable Growth Rate (SGR) reform package.
Under the cap for speech-language pathology and physical therapy
services, Medicare beneficiaries who suffer from speech-language disorders
due to life-altering events (e.g., stroke, head injury, Alzheimer's,
Parkinson's) risk being denied therapy and/or forced to pay out-of-pocket
for services to help them regain their ability to communicate effectively.
Audiologyadult hearing screening, hearing aid and cochlear implant programming and counseling, and auditory
brainstem response testing
Speech-Language Pathologyreal time, interactive assessment and treatment for beneficiaries with stroke, brain injury,
cancer, Parkinson's, and other medical conditions, such as disorders in swallowing (dysphagia), speech (dysarthria or
apraxia), language (aphasia), cognitive communication, and voice (dysphonia)
Telehealth expands Medicare beneficiaries access to audiology and speech-language pathology services and can alleviate
provider shortages by extending clinical services to remote, rural, or underserved populations.
Support legislation that would reauthorize the Early Hearing Detection and
Intervention (EHDI) program. This legislation would reauthorize the federal
portion of this important and highly successful initiative for the next 5 years.
Medicare Beneficiary
Devices (SGDs)
to
Access
Speech-Generating
Support the Steve Gleason Act of 2015 (H.R. 628), legislation that allows for the
immediate purchase and transfer of ownership of speech-generating devices (SGDs)
to the Medicare beneficiary and remove the devices from the Medicare capped-rental
requirements.
CMS has applied a capped-rental rule, requiring patients to rent SGDs over a
13-month period before owning the device.
Capped-rental adversely affects patients in an extended hospital stay or in a
skilled nursing facility, becausewhile the patient is in the rental period
Medicare will not cover the rental fees.
The agency has indicated that the capped-rental issue must be addressed
through legislation.
H.R. 628 will resolve this issue by removing the capped-rental requirement for speechgenerating devices and ensure that beneficiaries have access to eye-tracking
accessories for the devices.
Contact Us
Give us a call or e-mail us
for more information
ASHA
444 North Capitol St. NW
Suite 715
Washington, DC 20001
202-624-5951
ilusis@asha.org
Visit us on the web at
www.asha.org/advocacy